nference, inc.

Biotechnology company · Cambridge, Massachusetts, United States

nference, inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $300,000 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $2.7 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

nference at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

SEC CIK1806274

What does nference do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $300,000 in total (2022).

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $2.7 million sold (2022).

Frequently asked questions about nference

Where is nference headquartered?

nference, inc. is headquartered in Cambridge, Massachusetts, United States.

What does nference do?

nference, inc. is a biotechnology company.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences